Attention Business/Financial Editors

Noveko International Inc. Announces Preliminary Commercial Discussions between Noveko Trading 2008 LLC and Microban International, Ltd.

	    TSX: EKO

	    MONTREAL, March 24 /CNW Telbec/ - Noveko International Inc. (the
"Company") is pleased to announce that its European subsidiary, Noveko Trading
2008 LLC ("Noveko Trading"), and Microban International, Ltd., a leading
manufacturer and distributor of antimicrobial solutions for consumer,
industrial and medical products, have engaged in preliminary discussions about
a potential commercial relationship. No formal agreement has been entered
into, but the parties have identified several opportunities where such
collaboration could potentially be very attractive. Noveko Trading will be
responsible for most of the international distribution of the products of the
Company's subsidiaries.

	    Profile

	    Noveko International Inc. offers innovative health and environmental
protection solutions with the objective of improving collective well-being.
The Company, through its subsidiaries, specializes in the following business
segments: the development and marketing of products in the biomedical and
environmental fields, specifically face masks, air filters and other
antimicrobial products and - the development, manufacturing and marketing of
medical equipment, primarily portable real-time ultrasound scanners for use in
human and veterinary medicine.

	    Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are identified by
the use of terms such as "may", "could", "might", "intend", "should",
"expect", "project", "plan", "believe", "estimate" or other comparable
variants. These statements are based on the information available at the time
they are written, on assumptions made by management and on the expectations of
management, acting in good faith, regarding future events, including those
relating to economic conditions, fluctuations in exchange rates and operating
expenses, and the absence of unusual events entailing supplementary
expenditures. Although management considers these assumptions and expectations
reasonable based on the information available at the time they are written,
they could prove inaccurate. Forward-looking statements are also subject, by
their very nature, to known and unknown risks and uncertainties such as those
related to the industry, acquisitions, labor relations, credit, key officers,
supply and product liability. The actual results of Noveko International Inc.
could differ materially from those indicated or underlying these
forward-looking statements. The reader is therefore recommended not to unduly
rely on these forward-looking statements. Forward-looking statements do not
reflect the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. The Company undertakes no obligation to update or revise the
forward-looking statements to account for new events or new circumstances,
except where provided for by applicable legislation.





-30-

	    /For further information: Chantal Vennat, Director, Investor Relations
and Corporate Communications, Noveko International Inc., (514) 875-0606,
http://www.noveko.com/